TRPA1 and COVID-19: Moreover, the proof‐of‐concept study in a very limited number of patients has led to the hypothesis that combined Nrf2‐TRPA1 foods may be beneficial for some COVID‐19 symptoms and that there is a synergy between Nrf2 and TRPA1 agonists.